The Worst Is Over for Generic-Drug Stocks

  • 📰 WSJ
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

ایران اخبار اخبار

ایران آخرین اخبار,ایران سرفصلها

Heard on the Street: There are signs that the generic-drug industry’s long stock-market nightmare is ending, CGrantWSJ writes

این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

 /  🏆 98. in İR
 

از نظر شما متشکرم. نظر شما پس از بررسی منتشر خواهد شد.

ایران آخرین اخبار, ایران سرفصلها

Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.

Generic-drug industry is riddled with price-fixing schemes, investigators sayWhat started as an antitrust lawsuit brought by states over just two drugs in 2016 is said to have exploded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs. Probably a legally mandated formula how much drug companies can raise price above net cost is needed. ellewoodsgolfs This doesn’t surprise me. I pay $1400 for a 90-day supply of my generic colitis drug. The consumers have been feeling this for quite some time.
منبع: latimes - 🏆 11. / 82 ادامه مطلب »